Search Results

There are 71957 results for: content related to: Opioid Antagonists with Minimal Sedation for Opioid Withdrawal 1

  1. Opioid Antagonists Under Heavy Sedation or Anaesthesia for Opioid Withdrawal1

    Alcohol and Drug Misuse

    Iosief Abraha, Cristina Cusi, Pages: 113–114, 2012

    Published Online : 13 AUG 2012, DOI: 10.1002/9781118454503.ch43

  2. The TIPP opioid peptide family: Development of δ antagonists, δ agonists, and mixed μ agonist/δ antagonists

    Peptide Science

    Volume 51, Issue 6, 1999, Pages: 411–425, Peter W. Schiller, Grazyna Weltrowska, Irena Berezowska, Thi M.-D. Nguyen, Brian C. Wilkes, Carole Lemieux and Nga N. Chung

    Version of Record online : 20 APR 2000, DOI: 10.1002/(SICI)1097-0282(1999)51:6<411::AID-BIP4>3.0.CO;2-Z

  3. Opioid Antagonists for Alcohol Dependence1

    Alcohol and Drug Misuse

    Iosief Abraha, Cristina Cusi, Pages: 46–48, 2012

    Published Online : 13 AUG 2012, DOI: 10.1002/9781118454503.ch17

  4. Conformation–activity relationships of opioid peptides with selective activities at opioid receptors

    Peptide Science

    Volume 51, Issue 6, 1999, Pages: 391–410, Victor J. Hruby and Richard S. Agnes

    Version of Record online : 20 APR 2000, DOI: 10.1002/(SICI)1097-0282(1999)51:6<391::AID-BIP3>3.0.CO;2-X

  5. Opioids

    Pain Management in Veterinary Practice

    Christine M. Egger, Lydia Love, Tom Doherty, Pages: 39–67, 2014

    Published Online : 18 JUL 2014, DOI: 10.1002/9781118999196.ch4

  6. Medication Development for Nicotine Addiction

    Drug Discovery for the Treatment of Addiction: Medicinal Chemistry Strategies

    Brian S. Fulton, Pages: 230–239, 2014

    Published Online : 26 SEP 2014, DOI: 10.1002/9781118943670.ch8

  7. Drug Interaction

    Principles and Practice of Pharmacology for Anaesthetists, Fifth Edition

    T. N. Calvey, N. E. Williams, Pages: 68–85, 2008

    Published Online : 10 DEC 2008, DOI: 10.1002/9781405194853.ch4

  8. Cholecystokinin Antagonists

    Pain Management: Expanding the Pharmacological Options

    Gary J. McCleane, Pages: 73–82, 2009

    Published Online : 30 JAN 2009, DOI: 10.1002/9781444300796.ch12

  9. You have free access to this content
    Keyword index

    Anaesthesia

    Volume 57, Issue 12, December 2002, Pages: 1264–1267,

    Version of Record online : 18 NOV 2002, DOI: 10.1046/j.1365-2044.2002.t01-1-05712.x

  10. Dmt and opioid peptides: A potent alliance

    Peptide Science

    Volume 71, Issue 2, 2003, Pages: 86–102, Sharon D. Bryant, Yunden Jinsmaa, Severo Salvadori, Yoshio Okada and Lawrence H. Lazarus

    Version of Record online : 5 MAY 2003, DOI: 10.1002/bip.10399

  11. Opioid antagonists with minimal sedation for opioid withdrawal

    Intervention Review

    The Cochrane Library

    Linda Gowing, Robert Ali and Jason M White

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD002021.pub3

  12. Buprenorphine for the Management of Opioid Withdrawal1

    Alcohol and Drug Misuse

    Iosief Abraha, Cristina Cusi, Pages: 99–101, 2012

    Published Online : 13 AUG 2012, DOI: 10.1002/9781118454503.ch38

  13. A LACK OF POTENCY FOR THE δ-OPIOID ANTAGONIST NALTRINDOLE AFTER MICROINJECTION INTO THE ROSTRAL VENTROLATERAL MEDULLA OF RABBITS

    Clinical and Experimental Pharmacology and Physiology

    Volume 17, Issue 7, July 1990, Pages: 527–530, David Morilak, Guy Drolet and John Chalmers

    Version of Record online : 28 JUN 2007, DOI: 10.1111/j.1440-1681.1990.tb01353.x

  14. 6β-Naltrexol, a Peripherally Selective Opioid Antagonist that Inhibits Morphine-Induced Slowing of Gastrointestinal Transit: An Exploratory Study

    Pain Medicine

    Volume 12, Issue 12, December 2011, Pages: 1727–1737, Janet Yancey-Wrona, Brian Dallaire, Edward Bilsky, Brad Bath, John Burkart, Lynn Webster, Dan Magiera, Xiaoxia Yang, Mitch Phelps and Wolfgang Sadee

    Version of Record online : 28 NOV 2011, DOI: 10.1111/j.1526-4637.2011.01279.x

  15. Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors

    Addiction Biology

    Esa R. Korpi, Anni-Maija Linden, Heidi R. Hytönen, Nelli Paasikoski, Elena Vashchinkina, Mateusz Dudek, Deron R. Herr and Petri Hyytiä

    Version of Record online : 15 MAR 2016, DOI: 10.1111/adb.12393

  16. Efficacy and Safety of Mu-Opioid Antagonists in the Treatment of Opioid-Induced Bowel Dysfunction: Systematic Review and Meta-analysis of Randomized Controlled Trials

    Pain Medicine

    Volume 9, Issue 6, September 2008, Pages: 634–659, Ewan McNicol, David B. Boyce, Roman Schumann and Daniel Carr

    Version of Record online : 26 JUL 2007, DOI: 10.1111/j.1526-4637.2007.00335.x

  17. CLINICAL STUDY: Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial

    Addiction Biology

    Volume 14, Issue 2, April 2009, Pages: 204–213, Paolo Mannelli, Ashwin A. Patkar, Kathi Peindl, David A. Gorelick, Li-Tzy Wu and Edward Gottheil

    Version of Record online : 19 AUG 2008, DOI: 10.1111/j.1369-1600.2008.00119.x

  18. Pharmacotherapy for Opioid Withdrawal

    Treating Alcohol and Drug Abuse: An Evidence Based Review

    Mats Berglund, Sten Thelander, Egon Jonsson, Pages: 415–463, 2004

    Published Online : 15 APR 2004, DOI: 10.1002/3527601465.ch7

  19. Interaction of μ-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice

    European Journal of Pain

    Volume 9, Issue 5, October 2005, Page: 599, Babette Kögel, Thomas Christoph, Wolfgang Straβburger and Elmar Friderichs

    Version of Record online : 11 JAN 2012, DOI: 10.1016/j.ejpain.2005.02.002

  20. Suppression of Ethanol Responding by Centrally Administered CTOP and Naltrindole in AA and Wistar Rats

    Alcoholism: Clinical and Experimental Research

    Volume 25, Issue 1, January 2001, Pages: 25–33, Petri Hyytiä and Kalervo Kiianmaa

    Version of Record online : 11 APR 2006, DOI: 10.1111/j.1530-0277.2001.tb02123.x